Matarin Capital Management, LLC - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 155 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$2,631,000
-37.3%
762,489
-7.9%
0.19%
-38.4%
Q1 2019$4,195,000
-99.9%
827,462
-1.3%
0.30%
+24.5%
Q4 2018$3,027,415,000
-14.2%
838,619
+39.7%
0.24%
+7.5%
Q3 2018$3,529,311,000600,2230.23%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 120,600$416,0000.29%
Matarin Capital Management, LLC 762,489$2,631,0000.19%
DELTEC ASSET MANAGEMENT LLC 204,513$706,0000.16%
GLOBEFLEX CAPITAL L P 213,991$738,0000.15%
TSP Capital Management Group, LLC 88,750$306,0000.14%
Spark Investment Management LLC 512,500$1,768,0000.12%
OXFORD ASSET MANAGEMENT LLP 1,141,332$3,938,0000.08%
ALGERT GLOBAL LLC 66,842$231,0000.08%
CIGNA INVESTMENTS INC /NEW 188,018$645,0000.07%
Connor, Clark & Lunn Investment Management Ltd. 3,103,949$10,709,0000.07%
View complete list of ASSERTIO THERAPEUTICS INC shareholders